EN
HI
Summary
As of 7 Sep, 2026, Aarti Pharmalabs stock price is ₹858.8. During the trading session, the stock has moved between an intraday low of ₹854.10 and an intraday high of ₹879.75. Over the last 52 weeks, Aarti Pharmalabs has traded between ₹585.00 and ₹946.10.
The stock has recorded a trading volume of 4,63,265 shares, with a market capitalization of ₹90657751. Its Average Traded Price (ATP) is ₹862.15, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 57 @ ₹858.80.
Aarti Pharmalabs has an upper circuit limit of ₹1030.55 and a lower circuit limit of ₹687.05. The total value traded stands at ₹39.94 CR, and the delivery percentage for the day is 36.64%.
The stock is currently traded with a market lot size of 1. Aarti Pharmalabs also offers a dividend yield of 0.41%.
Aarti Pharmalabs share price chart
Aarti Pharmalabs Share Key Metrics
Volume
4.63 L
Market Cap
7785.69 CR
LTQ@LTP
57@858.80
ATP
862.15
Var Margin
22.33 %
Circuit Range
687.05-1030.55
Delivery %
36.64 %
Value
39.94 CR
ASM/GSM
No
Market Lot
1
Aarti Pharmalabs Fundamentals
P/E Ratio
36.59
P/B Ratio
3.56
Div. Yield
0.41
Sector P/E
41.43
Sector P/B
3.55
Sec. Div. Yield
0.5
Aarti Pharmalabs Resistance and Support
Pivot 869.85
Resistance
First Resistance
885.2
Second Resistance
902.3
Third Resistance
917.65
Support
First Support
852.75
Second Support
837.4
Third Support
820.3
Aarti Pharmalabs Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Sep 04 2026 | 872 | 858.8 | -1.07% | 879.75 | 854.1 |
| Thu Sep 03 2026 | 867.25 | 868.09 | 0.10% | 886.95 | 854.5 |
| Wed Sep 02 2026 | 866 | 867.25 | 0.24% | 879.4 | 859.5 |
Aarti Pharmalabs Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-07 | Quarterly Results |
| 2026-05-25 | Audited Results & Final Dividend |
| 2026-05-18 | Audited Results & Final Dividend |
| 2026-02-09 | Quarterly Results & Interim Dividend |
| 2025-11-09 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-10 | Audited Results & Final Dividend |
| 2025-02-05 | Quarterly Results |
| 2024-10-28 | Quarterly Results |
| 2024-08-05 | Quarterly Results |
Aarti Pharmalabs News
Aarti Pharmalabs Ltd - 543748 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Aarti Pharma Labs received a regulatory order totaling Rs. 59.50 crore, comprising stamp duty and penalty related to its demerger. The company believes it has a strong case and will challenge the order.
Sep 02 2026 20:29:38
Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Change in Management
Aarti Pharma Labs announced the resignation of Shri G.M. Naidu, Manufacturing/Sr. General Manager and Chief of Operations, effective August 31, 2026. His departure is attributed to personal commitments and professional aspirations.
Aug 31 2026 19:44:26
Read More
Aarti Pharmalabs Management
| Name | Position |
|---|---|
| Jeevan Mondkar | Company Secretary |
| Chandrakant V Gogri | Chairman Emeritus |
Aarti Pharmalabs Similar Stocks
Strides Pharma Science Ltd.
1059.60
6.00 (0.57%)
Jupiter Life Line Hospitals Ltd.
286.45
-3.85 (1.33%)
Yatharth Hospital & Trauma Care Services Ltd.
991.10
28.80 (2.99%)
Thyrocare Technologies Ltd.
576.15
-2.50 (0.43%)
Procter & Gamble Health Ltd.
5660.00
-97.50 (1.69%)
Sanofi India Ltd.
3158.20
-32.60 (1.02%)
Symbiotec Pharmalab Ltd.
1078.25
1.40 (0.13%)
Nephrocare Health Services Ltd.
697.05
-9.70 (1.37%)
Aarti Pharmalabs FAQs
The Buying Price of Aarti Pharmalabs share is 858.8 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Aarti Pharmalabs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aarti Pharmalabs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Aarti Pharmalabs shares is 36.59. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Aarti Pharmalabs shares is 3.56. Useful to assess the stock's value relative to its book value.
To assess Aarti Pharmalabs’s valuation compare Sector P/E, P/B which are 41.43 & 3.55 with sector averages, along with growth rates and financial metrics.
The Market Cap of Aarti Pharmalabs is 7785.69 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Aarti Pharmalabs share price is 946.10 & 585.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Aarti Pharmalabs belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in AARTIPHARM
Or Download Choice FinX App
Invest in AARTIPHARM
Account Opening Fee- AMC for 1st Year
- Auto Square Off Charges
- Call & Trade